Lymphadenopathy associated with Leishmania braziliensis cutaneous infection
- PMID: 1449199
- DOI: 10.4269/ajtmh.1992.47.587
Lymphadenopathy associated with Leishmania braziliensis cutaneous infection
Abstract
Lymph node involvement by Leishmania during human cutaneous leishmaniasis was reported more than 90 years ago, but the importance of certain Leishmania strains in such dissemination remains largely speculative. We have examined 36 consecutively untreated cutaneous leishmaniasis patients early in their disease; 66.7% had enlarged lymph nodes. Patients with enlarged lymph nodes had higher anti-Leishmania immune responses than patients without such involvement, both at the IgG antibody level (mean +/- SD optical density at 492 nm = 0.163 +/- 0.089 versus 0.098 +/- 0.086; P = 0.009) and in skin test responses (12.4 +/- 10.2 mm versus 5.7 +/- 7.3; P = 0.03). Thirteen (62%) of 21 lymph node cultures and 16 (53%) of 30 cultures from cutaneous sites were positive for Leishmania. Eleven of 13 isolates from lymph nodes were characterized by a panel of monoclonal antibodies, and all were typed as L. braziliensis. Our findings stress the importance of L. braziliensis as an agent involved in the early invasion of the lymphatic system.
Similar articles
-
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil.Am J Trop Med Hyg. 1995 Oct;53(4):380-5. doi: 10.4269/ajtmh.1995.53.380. Am J Trop Med Hyg. 1995. PMID: 7485690
-
Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis.Am J Trop Med Hyg. 1995 Sep;53(3):256-9. doi: 10.4269/ajtmh.1995.53.256. Am J Trop Med Hyg. 1995. PMID: 7573708
-
Cutaneous leishmaniasis associated with extensive lymphadenopathy during an epidemic in Ceará State, northeast Brazil.Acta Trop. 2005 Mar;93(3):303-10. doi: 10.1016/j.actatropica.2005.01.003. Acta Trop. 2005. PMID: 15716050
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
-
Cutaneous Manifestations of Human and Murine Leishmaniasis.Int J Mol Sci. 2017 Jun 18;18(6):1296. doi: 10.3390/ijms18061296. Int J Mol Sci. 2017. PMID: 28629171 Free PMC article. Review.
Cited by
-
Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.Front Immunol. 2016 Aug 3;7:287. doi: 10.3389/fimmu.2016.00287. eCollection 2016. Front Immunol. 2016. PMID: 27536300 Free PMC article.
-
Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.J Infect Dis. 2015 Jan 15;211(2):274-82. doi: 10.1093/infdis/jiu439. Epub 2014 Aug 19. J Infect Dis. 2015. PMID: 25139016 Free PMC article.
-
Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature.PLoS Negl Trop Dis. 2021 Apr 1;15(4):e0009321. doi: 10.1371/journal.pntd.0009321. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33793565 Free PMC article.
-
Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions.Pathogens. 2025 Feb 13;14(2):188. doi: 10.3390/pathogens14020188. Pathogens. 2025. PMID: 40005563 Free PMC article. Review.
-
Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.Eur J Immunol. 2010 Oct;40(10):2816-29. doi: 10.1002/eji.201040384. Eur J Immunol. 2010. PMID: 20827674 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical